CPT 85002–85999 Guide (2026)
- Med Cloud MD
- 2 days ago
- 13 min read
85002–85999 AMA CPT range: Hematology and Coagulation Procedures (Pathology & Laboratory) | 10–15% Hematology denial rate in 2026 above most medical specialty averages | 85999 Unlisted hematology/coagulation code requires special documentation | NCCI Bundles dozens of code combinations in this range know before you bill |
Introduction: Why Hematology Laboratory Coding Is Where Revenue Gets Lost
It takes less than four seconds for a modern hematology analyzer to generate a complete blood count. It takes considerably longer often weeks to recover the revenue from a CBC claim that was denied for a reason that a coding review would have caught in 30 seconds. That asymmetry between how fast diagnostic testing happens and how slowly billing errors get resolved is the central financial reality of running a hematology or laboratory billing operation in 2026.
The CPT code range 85002 through 85999 covers every hematology and coagulation procedure in the AMA code set: blood counts (automated and manual), coagulation studies, sedimentation rates, reticulocyte counts, hemoglobin electrophoresis, osmotic fragility testing, platelet function studies, and the unlisted code 85999 for procedures without a specific code. Across this range, the most common billing errors are predictable and preventable: billing CPT 85025 and 85049 on the same claim when the platelet count is already bundled inside 85025, submitting repeat coagulation panels without documenting why the frequency was clinically necessary, ordering a manual differential (85007) and an automated CBC with differential (85025) on the same date without understanding why that combination is an NCCI violation.
Understanding these codes which ones bundle, which ones require specific documentation, which ones have payer-specific frequency limits, and how to select the right one when multiple options exist is not just a coding exercise. It is the foundation of a compliant, revenue-protected laboratory billing operation. This guide gives hematology practices, independent laboratories, oncology groups, and billing managers the 2026 reference they need to get it right the first time.
WHAT IS THE CPT 85002–85999 CODE RANGE? The CPT code range 85002–85999 covers Hematology and Coagulation Procedures as defined by the AMA's Current Procedural Terminology code set, maintained within the Pathology and Laboratory section. This range includes: ✓ Blood count procedures: manual and automated CBC components, differentials, reticulocyte counts ✓ Coagulation studies: PT (85610), PTT/aPTT (85730), fibrinogen (85384/85385), D-dimer (85379), factor assays (85230–85293) ✓ Hemoglobin studies: hemoglobin electrophoresis (85280, 85290), fetal hemoglobin (85460/85461) ✓ Platelet function and sedimentation: bleeding time (85002), osmotic fragility (85555/85557), ESR (85651, 85652) ✓ Bone marrow smear evaluation (85097) separate from bone marrow procedure codes 38220–38222 ✓ Flow cytometry interpretation components not separately listed (see 88180–88189 for flow cytometry) ✓ 85999: unlisted hematology/coagulation procedure — requires manual review with documentation submitted to payer |
The 4 Clinical Categories of CPT 85002–85999
The most practical way to understand this code range is by clinical category. Most billing errors happen when coders apply a code from the wrong category or select the lower-included code when the comprehensive code is more appropriate. Here is how the range breaks down:
Commonly Billed CPT Codes Within 85002–85999: 2026 Reference Table
The following codes represent the highest-frequency billing codes within the hematology range. Each carries specific documentation requirements and NCCI considerations that affect first-pass clean claim rates.
Documentation Requirements for Hematology CPT 85002–85999
Documentation failure not incorrect code selection is the number one driver of laboratory claim denials in 2026. The structure of what you document determines what gets paid, what gets denied, and what triggers post-payment audit. Here is the complete framework:
HEMATOLOGY LAB BILLING DOCUMENTATION CHECKLIST — 2026 PHYSICIAN ORDER — THE COMPLIANCE FOUNDATION ✓ Order must specify the exact test requested — 'CBC with differential' authorizes 85025; 'CBC' alone authorizes only 85027; 'PT' authorizes 85610; 'aPTT' authorizes 85730 ✓ Ordering physician's full name and NPI number on every lab order submitted to Medicare ✓ Order date precedes or matches the date of service — retroactive orders are an audit flag ✓ For standing orders: active, dated, and signed; must include clinical indication, not just test name MEDICAL NECESSITY DOCUMENTATION ✓ Clinical indication for each test documented: specific symptom, diagnosis, or treatment monitoring rationale — not just 'as ordered' or 'lab work' ✓ ICD-10 diagnosis code linked to each CPT code on the claim must clinically explain why that specific test was needed ✓ For repeat testing within frequency limits: document the clinical change (new symptom, medication change, unexpected result) justifying early repeat ✓ For coagulation panels: document whether test is for monitoring (warfarin, heparin) or diagnostic (bleeding disorder workup) LABORATORY RECORD REQUIREMENTS ✓ CLIA certification type matches test complexity: automated CBC = moderate complexity; bone marrow smear interpretation = high complexity ✓ For 85007 (manual differential): confirm a pathologist or qualified physician performed manual cell review — documentation must reflect professional review ✓ Specimen type, collection date and time documented in laboratory record ✓ Analyzer output or test report filed with all components documented SPECIAL DOCUMENTATION REQUIREMENTS ✓ 85097 (bone marrow smear): pathologist's written interpretation required; cannot bill without documented morphology findings ✓ 85999 (unlisted): attach complete description of the procedure performed plus documentation supporting medical necessity; payer may request additional review ✓ Coagulation factor assays (85210–85293): each factor tested must be separately documented with clinical reason each was ordered ✓ Hemoglobin electrophoresis (85460): test method documented (HPLC vs. gel electrophoresis) as method determines correct code selection |
Step-by-Step Hematology Lab Billing Workflow
PATIENT ENCOUNTER — Clinical Indication Documented Treating provider documents the specific clinical indication for each ordered test. 'CBC' as an indication does not create medical necessity. 'Evaluating febrile neutropenia in patient receiving cycle 3 CHOP chemotherapy' creates medical necessity. The specificity of indication at the encounter level determines whether the claim survives audit. |
↓
PHYSICIAN ORDER — Test-Level Specificity Order precisely names each test: 'CBC with differential' (85025), 'PT and aPTT' (85610 + 85730), 'D-dimer quantitative' (85379). Generic orders like 'coag panel' or 'liver function plus CBC' must be translated into specific CPT codes — but only if each individual test in the panel was specifically requested and has separate medical necessity. |
↓
DIAGNOSIS VERIFICATION — ICD-10 Linkage Check Before sending the specimen to the analyzer, confirm the ICD-10 diagnosis code that will drive coverage for each test. A D-dimer (85379) ordered under Z00.00 (preventive exam) will be denied. The same D-dimer ordered under R79.1 (abnormal coagulation profile) or I26.99 (pulmonary embolism) will be covered. Catch the mismatch before the specimen is processed. |
↓
LABORATORY PROCESSING — Method Documentation Laboratory records must reflect the actual method used. For hemoglobin electrophoresis: was it HPLC (85460) or alkaline gel (85290)? For D-dimer: quantitative (85379) or semi-quantitative (85378)? For fibrinogen: clot-based (85384) or immunological (85385)? The code must match the method — billing the wrong method code is both a denial trigger and a compliance issue. |
↓
CORRECT CPT SELECTION — Comprehensive vs. Component Before assigning codes: determine whether a comprehensive code is appropriate or if individual component codes should be used. The key rule: when a comprehensive code includes components, billing both is unbundling. 85025 includes 85027, 85049, and automated differential. 85610 (PT) includes INR. 85379 (quantitative D-dimer) includes semi-quantitative interpretation. Always use the most comprehensive code that reflects what was actually performed. |
↓
ICD-10 VALIDATION — Coverage Linkage Every CPT code on the claim must be paired with an ICD-10 code that clinically supports that specific test. In hematology, this linkage is the most common denial source. A CBC (85025) can link to D50.0, D69.3, C91.00, or Z79.899. A D-dimer (85379) links to I26.99, D65, K74.60, or M32.10 — not to Z00.00. Build a standard ICD-10 crosswalk for your 20 most commonly ordered tests. |
↓
CLAIM REVIEW — NCCI & MUE CHECK Before submission: run each code combination against NCCI bundling edits. Cannot bill 85025 + 85007, 85025 + 85049, 85384 + 85385, 85345 + 85730 on the same claim for the same patient same day. Also check MUE limits — each code has a maximum units per day definition. If clinical documentation supports billing above the MUE, Modifier 59 or KX may apply depending on payer. |
↓
CLAIM SUBMISSION — Reference Lab Routing If the specimen was sent to a reference lab (Quest, LabCorp, hospital reference lab), the reference lab bills the CPT code. The ordering practice does NOT also bill the lab CPT codes for tests it sent out. This is the most common duplicate billing violation in multi-site practices with inconsistent charge capture templates. |
↓
PAYMENT POSTING — CLFS Rate Verification Post ERA and compare against the 2026 CMS Clinical Laboratory Fee Schedule rate for each code. Note: CLFS rates have been subject to a phased reduction under PAMA (Protecting Access to Medicare Act) that continued through 2025. Some commercial payers reimburse above CLFS; others at or below. Flag underpayments for dispute before the adjustment window closes. |
↓
DENIAL FOLLOW-UP — 48-HOUR STANDARD Denied hematology lab claims should be reviewed within 48 hours with root-cause categorization: frequency limit (CO-119), medical necessity (CO-50), code bundling (CO-97), missing documentation (CO-16), or diagnosis mismatch (CO-11). Each denial type has a different resolution workflow. Working all denials the same way wastes time and reduces recovery rates. |
Common Hematology Lab Claim Denials in 2026
Reimbursement Insights for Hematology Lab Codes in 2026
Laboratory reimbursement in 2026 continues to be shaped by two structural forces: PAMA-driven CLFS rate reductions that have compressed Medicare payments, and commercial payer utilization management programs that have tightened coverage policies for repeat and routine laboratory testing.
PRO TIP — Option 1 vs. Option 2 Revenue Decision When a CBC is ordered, the analyzer generates an automated differential, and the results are flagged as abnormal requiring pathologist manual review, practices have a choice: (1) Bill 85025 alone and absorb the manual review as part of the automated test, OR (2) Bill 85027 + 85007 when the manual review was separately performed and documented by a pathologist or qualified physician. The combined 85027 + 85007 rate typically exceeds the 85025 rate but only when the manual differential was actually documented by a qualified reviewer. Do not bill Option 2 unless the manual review is reflected in the chart. |
Compliance & Audit Risks for Hematology Laboratory Billing
The OIG Work Plan and CMS CERT data consistently identify laboratory billing as a high-error area — and within laboratory billing, hematology codes are among the most audited. Here is what to know about the specific compliance landscape in 2026:
• CMS CERT analysis has flagged physician order documentation deficiencies as the primary source of hematology lab billing errors — particularly missing or incomplete ordering provider information on reference lab claims submitted to Medicare
• Novitas Solutions and First Coast Service Options (FCSO) — both Medicare Administrative Contractors — have active documentation requirements for certain pathology and laboratory claims; practices in their jurisdictions should review current LCD requirements at least quarterly
• Duplicate billing between ordering practice and reference laboratory is a growing audit target as Medicare processes claims from both entities for the same test ordered by the same physician on the same date
• Frequency limit violations for CBC, PT, and aPTT in chronic disease monitoring are consistently in the top five denial reasons for laboratory claims under all major payers; repeat testing within 90 days requires specific, documented clinical change
• Flow cytometry (88180–88189) billing associated with hematology workups is a separate but related audit area; these codes require precise cell-marker documentation and cannot be bundled arbitrarily with CBC codes from the 85xxx range
2026 COMPLIANCE BEST PRACTICES — HEMATOLOGY LAB BILLING AUDIT PREVENTION CHECKLIST ✓ Quarterly coding audit: sample 20–30 hematology lab claims per provider per quarter; verify order language, CPT selection, ICD-10 linkage, and NCCI compliance ✓ NCCI edit cross-check: build a reference list of prohibited code combinations for your most frequently billed lab code pairs ✓ OIG Exclusion List: monthly screening of all performing and ordering providers non-optional for Medicare billing ✓ Standing order review: annually review standing orders for completeness date, signature, specific test, and indication ✓ CLIA certificate mapping: every code mapped to CLIA complexity tier; staff trained on what each certificate type allows ✓ Reference lab routing audit: monthly reconciliation confirming in-house vs. send-out tests are correctly routed in charge capture ✓ MedCloudMD AI billing intelligence: AI-assisted pre-submission review identifies coding patterns that exceed NCCI or MUE limits before claims submit |
How MedCloudMD Supports Hematology Laboratory Billing
MedCloudMD's hematology billing practice is built on specialty-specific expertise — not a general laboratory billing model that happens to include CBC codes. Our team understands the NCCI bundling rules for the 85xxx range, the Option 1 vs. Option 2 decision framework for CBC billing, the documentation requirements for bone marrow smear interpretation (85097), and the compliance implications of the 85999 unlisted code. This is not background knowledge it is operational expertise applied to every claim.
MedCloudMD Hematology Lab Capability | How It Improves Your Laboratory Revenue Performance |
CPT Code Selection Review | Pre-submission review confirms CPT code matches order language AND method performed. Prevents systematic 85025/85049 unbundling and 85025/85007 NCCI violations. |
NCCI Bundling Pre-Submission Scrubbing | Automated scrubbing rules prevent prohibited code combinations from reaching payer. 85025 + 85049, 85384 + 85385, 85345 + 85730 — blocked pre-submission. |
Medical Necessity & ICD-10 Alignment | Each CPT code verified against ICD-10 for clinical alignment before submission. Diagnosis-to-test mismatches caught before the CO-11 denial generates. |
Frequency Limit Tracking | Patient-level test history tracked by payer. Repeat testing within frequency windows flagged for documentation review before submission. |
Reference Lab Billing Audit | Monthly reconciliation confirming reference lab tests are suppressed in practice charges. Eliminates duplicate billing exposure at the source. |
Denial Management — 48-Hour Standard | Every lab denial categorized by CARC code and assigned for resolution within 48 hours. Systematic patterns addressed at the billing workflow level. |
MedCloudMD AI Billing Intelligence | AI-assisted pre-submission coding review identifies outlier patterns that exceed peer benchmarks or NCCI limits before claims submit. Compliance protection at scale. |
CLFS Rate Verification | ERA payments compared against 2026 CMS CLFS rates at code level. Systematic underpayments identified and disputed before adjustment window closes. |
KEY TAKEAWAYS — CPT 85002–85999 BILLING IN 2026 ✓ 85025 is the comprehensive CBC with automated differential — platelet count and differential are already bundled inside; do not add 85049 or 85007 ✓ 85025 + 85007 on the same date is an NCCI violation; choose Option 1 (85025 only) or Option 2 (85027 + 85007) ✓ 85610 (PT) includes INR calculation — do not separately bill INR as an add-on ✓ 85345 (PTT) and 85730 (aPTT) are distinct codes — bill the method actually performed; never bill both same day ✓ 85379 (D-dimer quantitative) vs. 85378 (semi-quantitative) — bill per method; cannot bill both same day ✓ 85384 (fibrinogen clot-based) vs. 85385 (immunological) — method determines code; cannot bill both same day ✓ 85097 (bone marrow smear) requires documented pathologist interpretation; cannot bill without written morphology findings ✓ 85999 (unlisted) always requires attached documentation; payer may require prior determination of medical necessity ✓ When specimen sent to reference lab: reference lab bills the CPT; ordering practice does NOT also bill ✓ CLFS rates set annually — verify current rates every January; PAMA reductions have been compressing Medicare lab reimbursement |
Frequently Asked Questions: CPT 85002–85999 Hematology Billing
Q1: What does the CPT code range 85002–85999 cover?
CPT codes 85002 through 85999 cover the Hematology and Coagulation Procedures section of the AMA's Pathology and Laboratory CPT code set. This range includes: complete blood count codes (85025, 85027, 85007, and component codes), coagulation studies (prothrombin time 85610, aPTT 85730, D-dimer 85379, fibrinogen 85384/85385, factor assays 85210–85293), hemoglobin studies (electrophoresis 85460/85280), reticulocyte counts (85044–85046), bone marrow smear evaluation (85097), platelet function testing, sedimentation rates (85651/85652), and the unlisted hematology procedure code 85999.
Q2: What is the difference between CPT 85025 and 85027?
CPT 85025 is a Complete Blood Count with automated differential white blood cell count, which includes Hgb, Hct, RBC, WBC, platelet count, RBC indices, and the automated 5-part differential. CPT 85027 is a CBC without differential same complete panel except the automated differential is not included. The correct code depends on what was specifically ordered: 'CBC with differential' or 'CBC with diff' = 85025; 'CBC' alone = 85027. Using 85025 when the physician only ordered 85027 is a compliance exposure that CERT analysis has flagged as an increasing billing error.
Q3: Can CPT 85025 and 85007 be billed together?
No. NCCI CCI edits prohibit CPT 85025 and CPT 85007 from being billed on the same date of service for the same patient. If an automated CBC with differential was ordered and a manual differential review was also performed, the correct approach is either: (1) Bill 85025 alone (Option 1, absorbing the manual review), or (2) Bill 85027 plus 85007 (Option 2, capturing the manual review component separately). The Option 2 combined rate ($8.89 + $4.73) often exceeds the 85025 standalone rate of $10.69, making it financially advantageous when the manual review is properly documented by a qualified physician.
Q4: What diagnoses support medical necessity for CPT 85025?
Any condition where quantification and characterization of blood cells is clinically necessary supports 85025. The most common: D50.0 (iron deficiency anemia), D61.x (aplastic anemia), D64.9 (anemia, unspecified), D69.3 (immune thrombocytopenia), C91–C96 (leukemia/lymphoma codes), D46.x (myelodysplastic syndrome), D70.x (neutropenia), Z79.899 (long-term drug use, as secondary diagnosis during chemotherapy monitoring), and infection codes when CBC is ordered for evaluation. The ICD-10 code must match the documented reason the CBC was ordered — Z00.00 (routine exam) does not create medical necessity for a diagnostic CBC under Medicare.
Q5: What is CPT 85999 and when should it be used?
CPT 85999 is the unlisted hematology and coagulation procedure code, used when a hematology-related procedure is performed that does not have a specific code in the 85002–85975 range. It requires manual payer review in most cases. When submitting 85999, always attach: a complete written description of the specific test performed, the medical necessity rationale, documentation from the patient chart, and any clinical evidence supporting the clinical utility of the test. Some payers require prior authorization before performing unlisted hematology procedures. Do not default to 85999 when a specific code exists if a specific code applies, use it.
Q6: How are frequency limits applied to hematology lab codes?
Medicare and most commercial payers apply frequency limits to high-volume hematology tests. For most chronic condition monitoring CBCs, the limit is every 90 days without additional documentation of clinical change. Coagulation monitoring for patients on anticoagulation therapy typically allows more frequent testing aligned with treatment protocols. To bill within a frequency limit window, the chart must document a specific clinical change: new symptoms, medication adjustment, unexpected prior result, or clinical deterioration. 'Routine monitoring' without a documented change is consistently denied with limited appeal success when frequency limits apply.
Q7: What NCCI edits apply most commonly in the 85002–85999 range?
The highest-impact NCCI edit pairs in the hematology range are: 85025 + 85049 (platelet count bundled in CBC), 85025 + 85007 (cannot bill automated and manual differential same day), 85384 + 85385 (fibrinogen clot-based and immunological methods same day), 85345 + 85730 (PTT and aPTT same day), and any CBC component code (85018, 85041) billed alongside a comprehensive CBC code that includes it. The NCCI edit database is updated quarterly; checking current edits before implementing new code combinations in your billing system is part of compliant laboratory billing practice.
Q8: When should a hematology practice outsource laboratory billing?
Outsourcing hematology laboratory billing is appropriate when: NCCI bundling violations are generating recurring denials that in-house staff cannot systematically prevent; reference lab billing overlaps are creating duplicate billing exposure; frequency limit denials exceed 5 percent of total lab claims; the billing team lacks expertise in the Option 1 vs. Option 2 CBC billing decision framework; or the quarterly coding audit is producing systematic errors that recur between audits. Specialty billing companies with hematology expertise provide the code-level knowledge and pre-submission scrubbing infrastructure that prevents these issues at scale.
About MedCloudMD: MedCloudMD is a U.S.-based medical billing and revenue cycle management company with specialized expertise in hematology and laboratory billing services. Our team manages CPT code accuracy, NCCI bundling compliance, frequency limit documentation, reference lab billing workflows, and denial management for hematology practices, oncology groups, and independent laboratories. This article reflects 2026 CPT, NCCI, and CMS CLFS guidance current as of June 2026. Always verify current payer-specific requirements and MAC LCD policies before claim submission.